Suggested dosing of bletilla striata (bai ji)
6-15g/d PO
Decoction used topically
Suggested uses of bletilla striata (bai ji)
Hemostatic (internal or topical use)
Primary hepatic carcinoma
Efficacy
Decrease tumor size & neovascularization in hepatic cancer
bletilla striata (bai ji) adverse (side) effects
Frequency not defined
Not specified
Warnings
Contraindications
Hypersensitivity
Pregnancy and lactation
Pregnancy category: N/A
Lactation: N/A
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of bletilla striata (bai ji)
Metabolism: N/A
Excretion: N/A
Mechanism of action
Astringent, stops blood flow
Promotes arterial embolization in hepatic cancer
